DDINet:基于多分子指纹特征和多头关注中心加权自编码器的药物相互作用预测网络
K Soni Sharmila1, Thanga Revathi S1, Pokkuluri Kiran Sree2
1School of Computing, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu 603203, India.
Journal of bioinformatics and computational biology
|April 1, 2025
概括
本研究介绍了DDINet,这是一个通过整合多个分子指纹和先进的深度学习来预测药物相互作用 (DDI) 的新型网络. DDINet显著提高了DDI预测的准确性,这对于药物发现和患者安全至关重要.
科学领域:
- 计算化学和化学信息学
- 药理学和药物发现
- 医疗保健中的人工智能
背景情况:
- 药物相互作用 (DDI) 是多药学中的一个重大问题,可能导致不良健康影响.
- 在早期药物发现和开发过程中,有效识别DDI至关重要,以确保患者的安全.
- 传统的DDI预测方法往往缺乏对复杂数据集的必要预测能力和可扩展性.
研究的目的:
- 提出一种新的药物相互作用预测网络 (DDINet),以提高预测性能.
- 利用多种分子指纹技术和先进的深度学习来改进DDI识别.
- 为处理大规模药物相互作用数据开发一个可扩展和强大的模型.
主要方法:
- 使用了DrugBank数据集,通过RDKit处理的简化分子输入线输入系统 (SMILES) 来表示药物.
- 使用多种分子指纹技术 (ECFP,MACCSkeys,PubChem,3D-FP,MDFP) 来生成特征向量.
- 集成了一个多头注意力集中权重自动编码器 (Mul_WAE) 与多头注意力 (MHA) 层,并使用升级的 Bald Eagle 搜索优化 (UBesO) 算法进行了优化.
主要成果:
- 实现了高预测精度 (99.77%),AUC (99.66%),平均精度 (99.5%),精度 (99.4%) 和回忆 (99.49%).
- 与现有的DDI预测方法相比,表现出优异的性能.
- 突出了该模型在特征提取和优化过程中的可扩展性和效率.
结论:
- 拟议的DDINet模型在DDI预测准确性和稳定性方面取得了重大进展.
- 多种分子指纹,MHA和UBesO算法的创新整合提高了预测能力.
- DDINet提供了一个可扩展的解决方案,用于识别潜在的药物相互作用,支持更安全的药物开发.
相关概念视频
Combined Effects of Drugs: Synergism
3.6K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.6K
Drug-Receptor Interactions
4.7K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
4.7K
Combined Effects of Drugs: Antagonism
8.2K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.2K
Factors Affecting Drug Response: Overview
1.7K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.7K
Drug Concentration Versus Time Correlation
544
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
544
Drug-Receptor Interaction: Antagonist
2.6K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
2.6K


